Methionine sulfoxide reductase (Msr) is a repair enzyme that reduces oxidized methionine to methionine. The Msr enzyme is divided into MsrA and MsrB, which reduce the S and R configurations of the substrate, respectively. In some pathogenic bacteria MsrA and MsrB exist in a fusion-protein form, MsrAB. In this study, the recombinant MsrA part of MsrAB from Haemophilus influenzae (HIMsrA) was overexpressed, purified and crystallized using the hanging-drop vapour-diffusion method. A diffraction data set was collected to 1.6 Å resolution. The crystal of HIMsrA was found to belong to space group P4 1 2 1 2, with unit-cell parameters a = b = 57.29, c = 186.28 Å , a calculated Matthews coefficient of 1.82 Å 3 Da À1 and two molecules per asymmetric unit. A preliminary solution was determined by molecular replacement. Refinement of the structure is currently in progress.
Introduction
Reactive oxygen species (ROS) are associated with various diseases and problems such as aging, cardiovascular diseases and cancer. Oxidative stress by ROS results in protein damage by inducing the oxidation of protein residues (Vogt, 1995) . Methionine is an easily oxidized amino acid and the oxidation of methionine to methionine sulfoxide can lead to protein damage or dysfunction (Hoshi & Heinemann, 2001; Kim & Gladyshev, 2007) . Methionine sulfoxide reductase (Msr) enzymes represent cellular repair systems for such protein oxidation and reduce methionine sulfoxide back to methionine (Skaar et al., 2002; Kantorow et al., 2004) . Methionine sulfoxide has two stereoisomeric forms because of the prochiral nature of the S atom: methionine-(S)-sulfoxide and methionine-(R)-sulfoxide. For the reduction of the R and S forms, two types of Msr exist: MsrA is specific for the S form, while MsrB only reduces the R form (Sharov & Schö neich, 2000; Grimaud et al., 2001) . MsrA and MsrB are typically separate in most organisms and there is no sequence homology between MsrA and MsrB. However, enzymatic studies have demonstrated that both enzymes have the same mechanism Kumar et al., 2002; Antoine et al., 2003; Olry et al., 2004; Kauffmann et al., 2005) . It has been reported that a single-enzyme combined form of MsrA and MsrB exists in some pathogenic bacteria such as Neisseria gonorrhoeae, Haemophilus influenzae and Streptococcus pneumoniae (Kryukov et al., 2002; Delaye et al., 2007) . To date, structural information has only been reported for a fusion MsrAB enzyme from S. pneumoniae (Kim et al., 2009; Lowther et al., 2002; Tê te-Favier et al., 2000) . This crystal structure, consisting of MsrA, MsrB and a linker, explained the potential role of the linker region in structural stability (Kim et al., 2009) . However, there are many other questions as to why MsrA and MsrB exist in a fused form in these bacteria. To better understand the structure and biochemical function of each part of the MsrAB fusion protein and to compare them with those of the whole fusion form, we cloned the MsrA and MsrB domains and the full MsrAB gene from H. influenzae. Here, we report the protein preparation, crystallization and preliminary X-ray crystallographic analysis of the MsrA domain.
Materials and methods

Cloning
The MsrA gene coding for 166 amino acids of MsrAB from H. influenzae (hereafter referred to as HIMsrA) was amplified by the polymerase chain reaction (PCR); the primers used were 5 0 -GGAATTCCATATGGAACAAAAAATGGCAATGGAAAAT-ACA-3 0 as the forward primer and 5 0 -CCGCTCGAGTTAGGTAA-TTAGGTAATATCAATATGGCAGTAGCCATT-3 0 as the reverse primer (NdeI and XhoI restriction-enzyme sites are shown in bold). The amplified DNA was digested with NdeI and XhoI and cloned into pET28a (Novagen). The recombinant protein has an N-terminal histidine tag and a thrombin cleavage site (MGSSHHHHHHSSG-LVPR/GSH, where / represents the thrombin cleavage site). The construct containing HIMsrA was transformed into Escherichia coli Rosetta (DE3) cells (Novagen) for protein expression. The transformed cells were grown in Luria-Bertani broth (LB) containing 50 mg ml À1 kanamycin to an OD 600 of 0.6 at 310 K. Overexpression of HIMsrA was induced by the addition of 0.5 mM isopropyl -d-1thiogalactopyranoside (IPTG) at 310 K. 2 h later, the cells were harvested using a centrifugal device (Hanil, Republic of Korea) at 1260g and 277 K and were stored at 257 K.
Purification
The cell pellets were resuspended in a lysis buffer (buffer A) consisting of 50 mM Tris pH 8.0, 100 mM NaCl, 2 mM -mercaptoethanol and were lysed by sonication on ice. The lysate was centrifuged for 45 min at 1260g and 277 K and the soluble part was filtered with a membrane filter (0.45 mm, Millipore) and loaded onto a nickelchelation column (HiTrap Chelating HP colum, GE Healthcare) equilibrated with buffer A. After washing in buffer A to remove nonspecifically bound bacterial proteins, His-tagged recombinant HIMsrA eluted at between 150 and 200 mM imidazole in a linear gradient to buffer B (buffer A with 500 mM imidazole). The N-terminal histidine tag was not removed. The eluted HIMsrA fraction was diluted tenfold with buffer C (50 mM Tris pH 9.0, 5 mM dithiothreitol). Using a HiTrap Q HP column (GE Healthcare), the HIMsrA was purified by anion-exchange chromatography and eluted at between 100 and 150 mM NaCl with buffer D (buffer C with 500 mM NaCl). The purified protein was concentrated using an Amicon ultracentrifugal concentrator (10 kDa cutoff, Millipore) at 1260g and loaded onto a gel-filtration column (Superdex 75, 120 ml, GE Healthcare) equilibrated with buffer E (50 mM Tris pH 8.0, 100 mM NaCl, 5 mM dithiothreitol). The collected purified HIMsrA was concentrated to 48 mg ml À1 in final buffer (buffer E) and stored at 193 K prior to use.
Crystallization
Initial crystallization conditions were screened using the sittingdrop vapour-diffusion method by seven initial crystallization screens with a Mosquito automated liquid-handling system (TTP LabTech). The kits used were PEG/Ion, SaltRx, Crystal Screen, Index, Natrix and MembFac from Hampton Research and the Wizard kit from Emerald BioSystems. Each 200 nl drop consisted of 100 nl HIMsrA protein solution and 100 nl reservoir solution and was equilibrated against 60 ml reservoir solution in a 96-well plate at 295 K. Of the various conditions used, square quasi-crystals were observed with a solution consisting of 3.5 M sodium formate, and optimization was performed to improve the quality of the crystals using the hangingdrop vapour-diffusion method. Diverse optimization conditions were tested using 3.0-4.0 M sodium formate, incubation temperatures of 295 and 297 K (room temperature) and varying the protein concentration and the protein:reservoir solution ratio. The best crystals were obtained when 3.5 M sodium formate was used as reservoir solution at a temperature of 297 K and the final protein concentration was 35 mg ml À1 . It was observed that the rounded quasi-crystals became square through the formation of corners over 10 d when the temperature was increased to 297 K.
Data collection and processing
To protect the crystals from radiation damage, the HIMsrA crystals were quickly transferred into a cryoprotectant solution (3.5 M sodium formate containing 25% ethylene glycol). The crystals were exposed at 100 K under a nitrogen stream on beamline BL1A of the Photon Factory (Tsukuba, Japan) using a Quantum 270 CCD detector (ADSC, Poway, USA). Data sets were collected to a resolution of 1.6 Å at a wavelength of 1.0 Å with a crystal-to-detector distance of 213.724 mm. Each frame had an exposure time of 3 s and 1 oscillation; the total oscillation range was 360 . All collected images were processed and scaled using the HKL-2000 package (Otwinowski & Minor, 1997) .
Results and discussion
Recombinant HIMsrA was expressed in E. coli and purified, with a yield of 60 mg per litre of culture. The purity, as obtained by SDS-PAGE, was greater than 95% and the final protein concentration for crystallization was 35 mg ml À1 (Fig. 1) . Initial crystals were obtained in 3.5 M sodium formate (Index condition No. 25) . After optimization of the crystallization temperature, the rounded crystals became square in shape through the formation of corners over a period of 10 d. The crystals had overall dimensions of approximately 0.1 Â 0.1 Â 0.05 mm (Fig. 2) . The crystals diffracted to a resolution of 1.6 Å ( Fig. 3) and belonged to the tetragonal space group P4 1 2 1 2 or P4 3 2 1 2, with unit-cell parameters a = b = 57.29, c = 186.28 Å . There were two molecules in the asymmetric unit, with a solvent content of 32.45% (based on the calculated unit-cell volume); the protein molecular weight was 21 328 Da and the Matthews coefficient (V M ) was 1.82 Å 3 Da À1 (Table 1) . Structure determination of HIMsrA was carried out by the molecular-replacement program Phaser (McCoy et al., 2007) using the MsrA domain of MsrAB from S. pneumoniae (PDB entry 3e0m; Kim et al., 2009 ) as the search model. A unique solution with a log-likelihood gain of 701.9 and a Z score of 26.7 was obtained when searching for two molecules in the asymmetric unit (space group P4 1 2 1 2, 1, reflections in the resolution range 1.6-28.7 Å ). In addition to electron-density inspection, initial cycles of rigid-body and restrained refinement improved the primary solution from an R factor of 36.5% and an R free of 44.2% to values of 31.7% and 35.2%, respectively, indicating a correct structure solution. Initial model building was performed automatically with PHENIX (Adams et al., 2002) . Structure refinement is now in progress. X-ray diffraction image of a crystal of H. influenzae MsrA. The resolution limit at the edge is 1.6 Å . 
